Россия
Россия
Россия
Россия
Россия
Настоящее исследование посвящено количественной оценке фракции внеклеточных объемов печени и селезенки при стадировании фиброза печени по данным магнитнорезонансной томографии.
фракция внеклеточного объема, фиброз печени, цирроз печени, хронические заболевания печени, стеатоз печени, магнитно-резонансная томография
1. Zhuang L., Zhang R., Ren S. et al. Global burden of metabolic dysfunction-associated steatotic liver disease from 1990 to 2021 and the prediction for the next 10 years // Preventive Medicine Reports. – 2025. – Vol. 59. – 103248. Doi:https://doi.org/10.1016/j.pmedr.2025.103248
2. Tham E.K.J., Tan D.J.H., Danpanichkul P. et al. The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021 // Liver International. – 2025. Doi:https://doi.org/10.1111/liv.70001
3. Borz-Baba L., Aydin A., Parvin R. Liver Biopsy in Metabolic-Associated Steatotic Liver Disease: Accuracy, Challenges and Alternatives // Cureus. – 2026. – Vol. 18. Doi:https://doi.org/10.7759/cureus.103284
4. Kupczyk P.A., Mesropyan N., Isaak A. et al. Quantitative MRI of the liver: Evaluation of extracellular volume fraction and other quantitative parameters in comparison to MR elastography for the assessment of hepatopathy // Magnetic Resonance Imaging. – 2021. – Vol. 77. – P. 7–13. Doi:https://doi.org/10.1016/j.mri.2020.12.005
5. Pavlides M., Mózes F.E. Editorial for “MRI Extracellular Volume Fraction in Liver Fibrosis – A Comparison of Different Time Points and Blood Pool Measurements” // Journal of Magnetic Resonance Imaging. – 2024. – Vol. 60. – № 4. – P. 1689–1690. Doi:https://doi.org/10.1002/jmri.29353
6. Mesropyan N., Isaak A., Faron A. et al. Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension // European Radiology. – 2021. – Vol. 31, № 1. – P. 85–93. Doi:https://doi.org/10.1007/s00330-020-07080-5
7. Mesropyan N., Kupczyk P., Kukuk G.M. et al. Diagnostic value of magnetic resonance parametric mapping for non-invasive assessment of liver fibrosis in patients with primary sclerosing cholangitis // BMC Medical Imaging. – 2021. – Vol. 21. – 65. Doi:https://doi.org/10.1186/s12880-021-00598-0
8. Obmann V.C., Ardoino M., Klaus J. et al. MRI extracellular volume fraction in liver fibrosis: a comparison of different time points and blood pool measurements // Journal of Magnetic Resonance Imaging. – 2024. – Vol. 60, № 4. – P. 1678–1688. Doi:https://doi.org/10.1002/jmri.29259
9. Catucci D., Obmann V.C., Berzigotti A. et al. Noninvasive assessment of clinically significant portal hypertension using ΔT1 of the liver and spleen and extracellular volume of the spleen on routine Gd-EOB- DTPA liver MRI // European Journal of Radiology. – 2021. – Vol. 144. – 109958. Doi:https://doi.org/10.1016/j.ejrad.2021.109958
10. Wang H.Q., Jin K.P., Zeng M.S. et al. Assessing liver fibrosis in chronic hepatitis B using MR extracellular volume measurements: comparison with serum fibrosis indices // Magnetic Resonance Imaging. – 2019. – Vol. 59. – P. 39–45. Doi:https://doi.org/10.1016/j.mri.2019.03.002
11. Terzi F.V.O., Parente D.B., Camargo G.C. et al. MRI-derived extracellular volume to assess liver fibrosis in patients with metabolic-associated steatotic liver disease // Abdominal Radiology (NY). – 2025. – Vol. 50, № 11. – P. 5223–5231. Doi:https://doi.org/10.1007/s00261-025-04945-5
